Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Centre Oscar Lambret
Mayo Clinic
Fujian Medical University
Mayo Clinic
NRG Oncology
University of Michigan Rogel Cancer Center
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
University of Arizona
University of Colorado, Denver
Dartmouth-Hitchcock Medical Center
Karolinska Institutet
Thomas Jefferson University
Sun Yat-sen University
UNICANCER
City of Hope Medical Center
Cardarelli Hospital
Centre of Postgraduate Medical Education
Gustave Roussy, Cancer Campus, Grand Paris
Poitiers University Hospital
Zhongshan People's Hospital, Guangdong, China
The University of Texas Health Science Center, Houston
Fox Chase Cancer Center
Technische Universität Dresden
Universidad Rey Juan Carlos
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
Cairo University
University of Chicago
Case Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Ohio State University Comprehensive Cancer Center
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
University of California, San Diego
Ohio State University Comprehensive Cancer Center
The Oxford Dental College, Hospital and Research Center, Bangalore, India
University Health Network, Toronto
Groupe Oncologie Radiotherapie Tete et Cou
Washington University School of Medicine
OHSU Knight Cancer Institute
Duke University
SB Istanbul Education and Research Hospital